Trial of resorbable mesh for hernia prevention
Becton, Dickinson and Company (BD) has completed enrolment in a clinical trial of resorbable mesh for preventing incisional hernias after open abdominal surgery.
Investigators enrolled 477 patients in the Prevent trial across 32 sites in the US and Europe to compare the effect of BD’s Phasix resorbable mesh and primary suture closure on the rate of incisional hernias.
The US-based medical technology company will follow patients through the trial’s primary endpoint at 24 months, beyond which it expects to use the data to seek Food and Drug Administration authorisation for the indication.
For the full story, see the October 2026 edition of Medical Textiles.
Image: BD